FindTestingLabs
Registers refreshed 2026-09-25.See refresh dates
France

ViVitro Labs SASU

Immeuble Energie, 24-26 Boulevard Gay Lussac, Marseille, 13014, France, Marseille, France

A2LA|3224.02ISO/IEC 17025Register refreshed 2026-09-25
Certificates
1
Scope items
4
Standards
9
Locations
1

Free. We check which accredited labs can do it, starting with this one, and reply within two working days with who can do it, how fast, and roughly what it costs.

Only the laboratory you pick gets your contact details. We ask the others without them.

Follow this lab

We will email you if this laboratory’s accreditation status or scope changes. No newsletter, only changes.

Work at ViVitro Labs SASU?

Claim this profile to keep it accurate.

Register record

A2LARefreshed
3224.02Active

Accredited standards

9

Our reading of the A2LA scope: each standard once, with its official name where we have checked it. Click a standard to see the scope line it comes from, word for word.

ASTM F2743Name not checked yet
As written on the certificate · Line 1 (A2LA 3224.02)

ISO 25539-2; ASTM F2743; AAMI TIR42; FDA guidance 1545; FDA guidance 1608; OLE1032; ISO 5840-1; ISO 5840-2; ISO 5840-3; ISO 5910; OLE1714; OLE2307

ISO 5840-1Cardiovascular implants - Cardiac valve prostheses - Part 1: General requirements
As written on the certificate · Line 1 (A2LA 3224.02)

ISO 25539-2; ASTM F2743; AAMI TIR42; FDA guidance 1545; FDA guidance 1608; OLE1032; ISO 5840-1; ISO 5840-2; ISO 5840-3; ISO 5910; OLE1714; OLE2307

ISO 5840-2Cardiovascular implants - Cardiac valve prostheses - Part 2: Surgically implanted heart valve substitutes
As written on the certificate · Line 1 (A2LA 3224.02)

ISO 25539-2; ASTM F2743; AAMI TIR42; FDA guidance 1545; FDA guidance 1608; OLE1032; ISO 5840-1; ISO 5840-2; ISO 5840-3; ISO 5910; OLE1714; OLE2307

ISO 5840-3Cardiovascular implants - Cardiac valve prostheses - Part 3: Heart valve substitutes implanted by transcatheter techniques
As written on the certificate · Line 1 (A2LA 3224.02)

ISO 25539-2; ASTM F2743; AAMI TIR42; FDA guidance 1545; FDA guidance 1608; OLE1032; ISO 5840-1; ISO 5840-2; ISO 5840-3; ISO 5910; OLE1714; OLE2307

ISO 5910Cardiovascular implants and extracorporeal systems - Cardiac valve repair devices
As written on the certificate · Line 1 (A2LA 3224.02)

ISO 25539-2; ASTM F2743; AAMI TIR42; FDA guidance 1545; FDA guidance 1608; OLE1032; ISO 5840-1; ISO 5840-2; ISO 5840-3; ISO 5910; OLE1714; OLE2307

ISO 7198Cardiovascular implants and extracorporeal systems - Vascular prostheses - Tubular vascular grafts and vascular patches
As written on the certificate · Line 2 (A2LA 3224.02)

ISO 25539-2; FDA Guidance 16007; OLE0811; OLE0813; ISO 7198; ISO 25539-1; OLE1215; OLE1512; OLE1513; FDA Guidance 1608; FDA Guidance 16007; FDA Guidance 1545; OLE0810; OLE0812; OLE1209; ISO 11070; OLE2209; OLE2210

ISO 11070Sterile single-use intravascular introducers, dilators and guidewires
As written on the certificate · Line 2 (A2LA 3224.02)

ISO 25539-2; FDA Guidance 16007; OLE0811; OLE0813; ISO 7198; ISO 25539-1; OLE1215; OLE1512; OLE1513; FDA Guidance 1608; FDA Guidance 16007; FDA Guidance 1545; OLE0810; OLE0812; OLE1209; ISO 11070; OLE2209; OLE2210

ISO 25539-1Cardiovascular implants - Endovascular devices - Part 1: Endovascular prostheses
As written on the certificate · Line 2 (A2LA 3224.02)

ISO 25539-2; FDA Guidance 16007; OLE0811; OLE0813; ISO 7198; ISO 25539-1; OLE1215; OLE1512; OLE1513; FDA Guidance 1608; FDA Guidance 16007; FDA Guidance 1545; OLE0810; OLE0812; OLE1209; ISO 11070; OLE2209; OLE2210

ISO 25539-2Cardiovascular implants - Endovascular devices - Part 2: Vascular stents
As written on the certificate · Line 1 (A2LA 3224.02)

ISO 25539-2; ASTM F2743; AAMI TIR42; FDA guidance 1545; FDA guidance 1608; OLE1032; ISO 5840-1; ISO 5840-2; ISO 5840-3; ISO 5910; OLE1714; OLE2307

As written on the certificate · Line 2 (A2LA 3224.02)

ISO 25539-2; FDA Guidance 16007; OLE0811; OLE0813; ISO 7198; ISO 25539-1; OLE1215; OLE1512; OLE1513; FDA Guidance 1608; FDA Guidance 16007; FDA Guidance 1545; OLE0810; OLE0812; OLE1209; ISO 11070; OLE2209; OLE2210

Scope as published by A2LA

4 lines
A2LA

ISO/IEC 17025

Active

3224.02

The scope document we hold says it is valid until 2027-01-31.

View scope

Accredited scope, certificate 3224.02

LineDisciplineMethodMatrixRange
1mechanicalISO 25539-2; ASTM F2743; AAMI TIR42; FDA guidance 1545; FDA guidance 1608; OLE1032; ISO 5840-1; ISO 5840-2; ISO 5840-3; ISO 5910; OLE1714; OLE2307Medical devices-200 to 300 mmHg
2mechanicalISO 25539-2; FDA Guidance 16007; OLE0811; OLE0813; ISO 7198; ISO 25539-1; OLE1215; OLE1512; OLE1513; FDA Guidance 1608; FDA Guidance 16007; FDA Guidance 1545; OLE0810; OLE0812; OLE1209; ISO 11070; OLE2209; OLE2210-0.5 to 1000 cm; °C; Kg; l/min; mmHg; mm; ”
3mechanical-fluidsto 10000 particles/ml
4mechanical---

Ranges are reproduced from the accredited scope document as published. An absent range means the register did not state one. Line numbers are ours, for cross-reference; they follow the order of the scope document.

Location

Immeuble Energie, 24-26 Boulevard Gay Lussac, Marseille, 13014, France, Marseille, FR

43.29617, 5.36995

Open in Maps

Accreditation data refreshed from the A2LA register on .

This page mirrors a public register. For a purchasing, audit or regulatory decision, confirm against the A2LA entry linked above.